Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
neurotransmitter GHB |
| gptkbp:abused_as |
recreational drug
date rape drug |
| gptkbp:actsOn |
gptkb:GABA-B_receptor
CNS depressant GHB receptor prodrug to GABA |
| gptkbp:antidote |
none specific
|
| gptkbp:boilingPoint |
204 °C
|
| gptkbp:CASNumber |
591-81-1
|
| gptkbp:category |
analgesic
neurotransmitter recreational drug sedative prodrug endogenous compound hydroxy acid GABA analog depressant short-chain fatty acid |
| gptkbp:chemicalFormula |
C4H8O3
|
| gptkbp:discoveredBy |
gptkb:Alexander_Zaytsev
|
| gptkbp:discoveredIn |
1874
|
| gptkbp:eliminationHalfLife |
30–60 minutes
|
| gptkbp:foundIn |
human body
|
| https://www.w3.org/2000/01/rdf-schema#label |
4-hydroxybutanoic acid
|
| gptkbp:IUPACName |
gptkb:4-hydroxybutanoic_acid
|
| gptkbp:legalStatus |
controlled substance in many countries
|
| gptkbp:meltingPoint |
44 °C
|
| gptkbp:metabolism |
gptkb:succinic_acid
|
| gptkbp:molecularWeight |
104.10 g/mol
|
| gptkbp:otherName |
GHB
gamma-hydroxybutyric acid |
| gptkbp:predecessor |
gptkb:GABA
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
nausea
dizziness drowsiness respiratory depression unconsciousness |
| gptkbp:solubility |
miscible
|
| gptkbp:usedFor |
analgesic
treatment for narcolepsy treatment for alcoholism |
| gptkbp:bfsParent |
gptkb:GHB
|
| gptkbp:bfsLayer |
7
|